A Blood Test Shows Promise for Early Colon Cancer Detection |
A new study published in the New England Journal of Medicine co-authored by Moores Cancer Center researcher Dr. Samir Gupta found that a majority of early staged and curable colorectal cancers were found when screening was performed via blood test rather than colonoscopies or at-home fecal tests. “I think this is going to start taking off,” said Dr. John M. Carethers, Vice Chancellor for Health Sciences at the University of California, San Diego. Read Dr. Carether’s editorial piece in the New England Journal of Medicine to learn more about the future of non-invasive colorectal cancer screening.
|
Research Spotlight: Cure Prize Team Leader Andrew Lowy, MD, PhD |
Curebound 2023 grant recipient Andrew Lowy, MD, PhD, on the recent Cure Prize project and the potential effect it will have on the standard of care in pancreatic cancer patients:
“My career has been dedicated to the care and cure of patients with pancreatic cancer. Our project builds on our team's discovery that blocking the function of Syk Kinase can engender an antitumor immune response to pancreatic cancer and enhance the effects of chemotherapy. We are incredibly excited to test this idea in pancreatic cancer patients who will undergo surgery. Curebound‘s support will make it possible for us to study the effectiveness of this approach in patients and to understand the science behind it. As the drug we will use is already FDA approved for other indications, if the successful, our study could result in a rapid change to the standard of care for pancreatic cancer patients.”
- Andrew Lowy, MD, PhD UC San Diego Health
|
Targeting Tumor and Tumor Microenvironment Dependencies at the Single Cell Level: Director's Seminar Series |
Join us on March 27, 2024 at 12:00 pm as Andrea Califano, PhD, discusses “Targeting tumor and tumor microenvironment dependencies at the single cell level,” the featured topic of this session of the Distinguished Scientist Director's Seminar Series.
|
Nominations for the National Medal of Science (NMS) Now Open! |
The National Medal of Science (NMS) is the highest recognition the nation can bestow on scientists and engineers. It was established by the 86th Congress in 1959 as a Presidential Award to be given to individuals "deserving of special recognition by reason of their outstanding contributions to knowledge in the physical, biological, mathematical, or engineering sciences." In 1980, Congress expanded this recognition to include the social and behavioral sciences.
The National Science Foundation is seeking nominations for the NMS from February 5 through May 3, 2024. Please share the NMS Call for Nominations flyer with your colleagues.
|
|
|
Rachel Stroud Hunsinger, Kristin Waller-Donovan, and John Matthews |
March 26, 2024 | 12:00 pm
Comer Commons
|
March 26, 2024 | 12:00 pm
Leichtag Biomedical Research Building Room 107
|
April 2, 2024 | 12:00 pm
Leichtag Biomedical Research Building Room 107
|
2024 Joint Distinguished UCSD Moores Cancer Center/UCSD Department of Pharmacology Annual Lecture |
April 4, 2024 | 12:00 pm
Goldberg Auditorium
|
April 17, 2024 | 12:00 p.m.
Comer Commons
|
Juan F. Javier-DesLoges, MD, MS |
May 1, 2024 | 12:00 p.m.
Comer Commons
|
|
|
AACR/ASCO Methods in Clinical Cancer Research Workshop |
The AACR/ASCO Methods in Clinical Cancer Research Workshop is an intensive workshop in the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer for clinical fellow and junior faculty clinical researchers in all oncology subspecialties, including radiation, surgical oncology, and radiology. Applications are due by Wednesday, March 27, 2024 at 1:00 p.m. ET.
For questions about the submission of your application online, contact Asiyah Bhallo at asiyah.bhallo@aacr.org. For all other questions about the Workshop, including eligibility, please contact Dean Post at dean.post@aacr.org.
|
Special Trainee Opportunity | Resilience in Academia: Getting Personal with Jennifer Guerriero, PhD |
Join Dr. Jennifer Guerriero on Thursday, April 4, from 10:00 a.m. to 11:00 a.m. to hear more about her journey in medicine and academia, including advice on non-linear career trajectories, mentoring, job market, personal life sacrifices, building a family during academic training, supporting peers, creating opportunities, networking, and more. There will be an additional opportunity to ask questions and enjoy lively discussion.
|
Surgical Oncologists As Scientists (SOAS) Training Program |
As a member of the next generation of translational surgeon-scientists, you will undergo rigorous training in three disciplines: 1) the tumor microenvironment; 2) techniques of biobanking; and 3) innovation and entrepreneurship. This is a truly unique, one of a kind training program, and is located at an elite institution with a Training Faculty composed of 18 NIH-funded ($28.1 million per year; $18.5 million in direct costs) Faculty Mentors. Applications must be submitted by April 15, 2024.
|
Cancer Therapeutics Training (CT2) Training Program |
The CT2 Program is open to both MDs and PhDs and provides an intensive 2-year period of research and training in the development of novel cancer therapeutics or diagnostics at the Moores Cancer Center. Trainees not only execute a research program under the direction of a member of the faculty of this Comprehensive Cancer Center, but also participate in coursework, seminars, and lectures. Graduates of the program are prepared to transition to leadership roles in cancer therapeutics development in either an academic or commercial environment. Applications must be submitted by April 15, 2024.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
NIH Resubmission Guideline Changes |
Effective May 25, 2024, for RESUBMISSION APPLICATIONS: The use of markups such as bracketing, indenting, highlighting, bolding, italicizing, underlining, margin lines, change in typography, font, or font color, or any other type of markup should NOT be used to identify changes in Resubmission applications.
Changes made to a Resubmission application should only be outlined in the Introduction attachment. The Introduction must include a summary of substantial additions, deletions, and changes to the application. It must also include a response to weaknesses raised in the Summary Statement. Unless otherwise indicated in the Table of Page Limits, the Introduction may not exceed one page.
NIH Guidance
|
The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.
LOI Due: April 29th, 2024
|
Pre-pilot project funding of up to $40K ($20K per institution) is intended to support UCSD/SDSU teams to implement small-scale activities with the expectation that preliminary findings will support proposals for additional funding. Projects must reflect a true collaboration between SDSU and UCSD co-leaders, and must address one or more of CREATE's priority cancer and cancer disparities areas.
Submission Deadline: May 8, 2024
|
|
|
|
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity |
Christopher K. Glass, MD, PhD (Cancer Biology and Signaling)
|
|
|
| CALLA trial: immunotherapy in locally advanced cervical cancer - Authors' reply |
Jyoti Mayadev, MD (Solid Tumor Therapeutics)
|
|
|
|
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer
|
William J. Kim, PhD (Structural and Functional Genomics)
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT |
American Society of Preventative Oncology Annual Meeting Recap |
The Community Outreach & Engagement team was honored to represent the Moores Cancer Center at the 48th annual American Society of Preventive Oncology in Chicago over the weekend! Among the agenda were some of our very own, Dr. Elena Martinez, Dr. Joshua Demb, Dr. Corinne McDaniels-Davidson, and Nasim Kasiri! We look forward to next year's conference in Philadelphia!
View Agenda Highlights
|
Cancer Health Equity Collaborative
|
Happening next week on Thursday, March 28th from 10am-12pm! Don't miss the Community Outreach & Engagement quarterly CHEC meeting. We'll be featuring insights from the San Diego County Cannabis Public Health Initiative, along with a presentation by MCC's own Dr. Mateo Banegas, who will delve into his upcoming pilot research on screening for social needs. Register today!
Register Now
|
The Science Of... Live Podcast Recording
|
March 28, 2024 | 4:30 p.m. to 6:30 p.m. |
Join the Community Outreach & Engagement team, in collaboration with CRTEC, Cloudcast Media, and the Jackie Robinson YMCA, for another live taping of their podcast, "The Science Of," on Thursday, March 28th, from 4:30-6:30pm at the Commer Commons! This week's episode will highlight Dr. David Gonzalez and Dr. Shir Gur-Cohen. Don't miss out- light refreshments available for all attendees!
RSVP Now
|
Jackie Robinson YMCA Health Fair
|
April 3, 2024 | 10:00 a.m. to 3:00 p.m. |
Join the Community Outreach & Engagement team at the upcoming Jackie Robinson YMCA health fair (151 YMCA Way, San Diego, CA 92102) on Wednesday, April 3rd, from 10 am-3 pm. This event will spotlight colorectal cancer and feature a giant interactive inflatable colon for all attendees to walk through! If you'd like to join the COE team at this event, reach out to us directly at mcccoe@health.ucsd.edu.
|
|
|
|
